Clinical trial
A Phase 2 Study of LY2606368 in Patients With Extensive Stage Disease Small Cell Lung Cancer
NCT02735980 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of LY2606368 in Patients With Extensive Stage Disease Small Cell Lung Cancer
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 11, 2016
- Completion date
- February 12, 2019
- Enrollment
- 133 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.
small cell lung cancer